HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remission of Merkel cell tumor after somatostatin analog treatment.

Abstract
We recently treated one patient presenting with a disseminated non-operable Merkel cell carcinoma (MCC) by lanreotide (somatostatin analog), with a complete remission of the disease and a follow up of 17 months. We present in this paper a case report with a review of the utilization of somatostatin analogues in the treatment of MCC.
AuthorsM Fakiha, P Letertre, J P Vuillez, J Lebeau
JournalJournal of cancer research and therapeutics (J Cancer Res Ther) 2010 Jul-Sep Vol. 6 Issue 3 Pg. 382-4 ISSN: 1998-4138 [Electronic] India
PMID21119285 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Somatostatin
Topics
  • Aged
  • Aged, 80 and over
  • Carcinoma, Merkel Cell (drug therapy, surgery)
  • Female
  • Humans
  • Immunohistochemistry
  • Remission Induction
  • Skin Neoplasms (drug therapy, surgery)
  • Somatostatin (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: